Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Expansion Trial of Transcutaneous Vagus Nerve Stimulation (tVNS) for Immune-Related Fatigue in Patients Receiving Immune Checkpoint Inhibitors

NCT07529431 is registered in ClinicalTrials.gov with University of Vermont Medical Center as lead sponsor.

NCT NCT07529431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07529431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Expansion Trial of Transcutaneous Vagus Nerve Stimulation (tVNS) for Immune-Related Fatigue in Patients Receiving Immune Checkpoint Inhibitors
Lead sponsor
University of Vermont Medical Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
July 31, 2035
Enrollment
13 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer-related fatigue